PEBAVAZ Trademark

Trademark Overview

On Friday, February 2, 2018, a trademark application was filed for PEBAVAZ with the United States Patent and Trademark Office. The USPTO has given the PEBAVAZ trademark a serial number of 87781821. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 2, 2021. This trademark is owned by Pfizer Inc.. The PEBAVAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases and disorders
pebavaz

General Information

Serial Number87781821
Word MarkPEBAVAZ
Filing DateFriday, February 2, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 2, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 12, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, August 2, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 2, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 4, 2021EXTENSION 5 GRANTED
Monday, December 14, 2020EXTENSION 5 FILED
Monday, January 4, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 14, 2020TEAS EXTENSION RECEIVED
Friday, May 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 27, 2020EXTENSION 4 GRANTED
Wednesday, May 27, 2020EXTENSION 4 FILED
Wednesday, May 27, 2020TEAS EXTENSION RECEIVED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019EXTENSION 3 GRANTED
Tuesday, December 17, 2019EXTENSION 3 FILED
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Wednesday, June 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2019EXTENSION 2 GRANTED
Monday, June 24, 2019EXTENSION 2 FILED
Monday, June 24, 2019TEAS EXTENSION RECEIVED
Wednesday, December 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 10, 2018EXTENSION 1 GRANTED
Monday, December 10, 2018EXTENSION 1 FILED
Monday, December 10, 2018TEAS EXTENSION RECEIVED
Tuesday, June 26, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 1, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 1, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 26, 2018ASSIGNED TO EXAMINER
Monday, February 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 6, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

pebavaz diseases disorders oncological treatment preparations pharmaceutical